↓ Skip to main content

Dove Medical Press

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Overview of attention for article published in Breast cancer targets and therapy, March 2017
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
89 Mendeley
Title
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response
Published in
Breast cancer targets and therapy, March 2017
DOI 10.2147/bctt.s115600
Pubmed ID
Authors

Sandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, Eldri Undlien Due, Dagim Shiferaw Tadele, Henrik Edgren, Olli Kallioniemi, Merja Perälä, Gunhild Mari Mælandsmo, Kristine Kleivi Sahlberg

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
China 1 1%
Unknown 88 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 26%
Researcher 13 15%
Student > Master 13 15%
Student > Bachelor 10 11%
Professor > Associate Professor 4 4%
Other 7 8%
Unknown 19 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 22%
Agricultural and Biological Sciences 12 13%
Medicine and Dentistry 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 7 8%
Immunology and Microbiology 5 6%
Other 14 16%
Unknown 22 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2017.
All research outputs
#20,567,353
of 25,837,817 outputs
Outputs from Breast cancer targets and therapy
#223
of 327 outputs
Outputs of similar age
#243,766
of 328,652 outputs
Outputs of similar age from Breast cancer targets and therapy
#16
of 24 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 327 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,652 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.